Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2010; 135(25/26): 1312-1314
DOI: 10.1055/s-0030-1255161
DOI: 10.1055/s-0030-1255161
Klinischer Fortschritt | Commentary
© Georg Thieme Verlag KG Stuttgart · New York
Immunologie 2010
Immunology 2010Further Information
Publication History
Publication Date:
16 June 2010 (online)
Was ist neu?
-
Genetische Fiebersyndrome: Innovative Biologika zugelassen.
-
Primäre Immundefekte: Von der genetischen Assoziation zur Funktion des Immunsystems.
-
Stammzelltransplantation und Gentherapie bei Immundefekten: Fortschritte nach Rückschlägen.
-
Hereditäres Angioödem: Neue genetische Assoziationen, neue Medikamente.
Literatur
- 1 Aiuti A, Cattaneo F, Galimberti S. et al . Gene therapy for immunodeficiency due to adenosine deaminase deficiency. N Engl J Med. 2009; 360 447-458
- 2 Boztug K, Appaswamy G, Ashikov A. et al . A syndrome with congenital neutropenia and mutations in G6PC3. N Engl J Med. 2009; 360 32-43
- 3 Craig T J, Levy R J, Wasserman R L. et al . Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol. 2009; 124 801-808
- 4 Duan Q L, Binkley K, Rouleau G A. Genetic analysis of Factor XII and bradykinin catabolic enzymes in a family with estrogen-dependent inherited angioedema. J Allergy Clin Immunol. 2009; 123 906-910
- 5 Glocker E O, Hennigs A, Nabavi M. et al . A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med. 2009; 361 1727-1735
- 6 Hentges F, Hilger C, Kohnen M, Gilson G. Angioedema and estrogen-dependent angioedema with activation of the contact system. J Allergy Clin Immunol. 2009; 123 262-264
- 7 Notarangelo L D, Fischer A. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies . Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol. 2009; 124 1161-1178
- 8 Lachmann H J, Kone-Paut I, Kuemmerle-Deschner J B. et al . Use of canakinumab in the cryopyrin-associated periodic syndrome. N Engl J Med. 2009; 360 2416-2425
- 9 Neven B, Leroy S, Decaluwe H. et al . Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009; 113 4114-4124
- 10 Routes J M, Grossman W J, Verbsky J. et al . Statewide newborn screening for severe T-cell lymphopenia. JAMA. 2009; 302 2465-2470
- 11 Stein S, Ott M G, Schultze-Strasser S. et al . Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med. 2010; 16 198-204
- 12 Straathof K C, Rao K, Eyrich M. et al . Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study. Lancet. 2009; 374 912-920
- 13 US Food and Drug Administration .FDA labelling information – Kalbitor (ecallantide). FDA website [online]. http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/125277lbl.pdf
- 14 Warnatz K, Salzer U, Rizzi M. et al . B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans. Proc Natl Acad Sci U S A. 2009; 106 13945-13950
Prof. Dr. med. Georg Behrens
Klinik für Immunologie und Rheumatologie, Medizinische
Hochschule Hannover
Carl-Neuberg-Str. 1
30625
Hannover
Phone: 0511/532-5713
Fax: 0511/532-5324
Email: Behrens.georg@mh-hannover.de